Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Keiretsu Forum
AddedFeb 15, 2024
UpdatedJul 16, 2026
Keiretsu Forum

Keiretsu Forum

Operating

Keiretsu Forum: A global angel investment network offering diverse venture and debt financing.

Location
San Francisco, CA, US
Founded
2000
Firm
Compare
Portfolio
Employees

Investments

iQure Pharma
iQure Pharma

Total Raised

$1.9M

Rounds

5

Series A$600kAugust 2022
Vartega
Vartega

Total Raised

$22.5M

Rounds

12

Seed$5MAugust 2022
Maxwell Biosciences
Maxwell Biosciences

Total Raised

$10.8M

Rounds

4

Seed$10.8MMarch 2022
New View Surgical
New View Surgical

Total Raised

$28.1M

Rounds

9

Series B$9MNovember 2021
Wordego
Wordego

Total Raised

$1.1M

Rounds

3

Seed$450kNovember 2021
Angel$200kNovember 2020
Swir Vision Systems
Swir Vision Systems

Total Raised

$7.5M

Rounds

5

Series A$5MOctober 2021
Xeno Biosciences
Xeno Biosciences

Total Raised

$8.8M

Rounds

5

Series A$7.3MAugust 2021
Spintly
Spintly

Total Raised

$2.3M

Rounds

3

Seed$650kApril 2021
UbiQD
UbiQD
Public

Total Raised

$20.7M

Rounds

10

Series A$4.5MDecember 2020
Elevāt
Elevāt

Total Raised

$12M

Rounds

2

Seed$9.5MNovember 2020
Clics
Clics

Total Raised

$1M

Rounds

5

Series UnknownNovember 2020
Light Line Medical
Light Line Medical

Total Raised

$5M

Rounds

4

Series UnknownNovember 2020
Soteria Battery Innovation Group
Soteria Battery Innovation Group

Total Raised

$6.6M

Rounds

5

Grant$25kNovember 2020
EternaTear
EternaTear

Total Raised

$4.9M

Rounds

2

Series A$4.9MOctober 2020
Vita Inclinata
Vita Inclinata
Series D

Total Raised

$71.3M

Rounds

7

Series B$20MOctober 2020
Reneva
Reneva

Total Raised

$400k

Rounds

1

Seed$400kAugust 2020
KitoTech Medical
KitoTech Medical

Total Raised

$15.9M

Rounds

7

Convertible Note$3MAugust 2020
HaptX
HaptX

Total Raised

$59.5M

Rounds

9

Series A$12MDecember 2019
11Sight
11Sight

Total Raised

$7.3M

Rounds

7

Seed$490kDecember 2019
AcuraStem
AcuraStem

Total Raised

$12M

Rounds

4

Convertible Note$1MNovember 2019
Syccure
Syccure

Total Raised

$70k

Rounds

2

Series UnknownOctober 2019
CleanFiber
CleanFiber

Total Raised

$63M

Rounds

18

Series Unknown$5MOctober 2019
OtoNexus Medical Technologies
OtoNexus Medical Technologies

Total Raised

$19.3M

Rounds

11

Private Equity$5MSeptember 2019
PittMoss
PittMoss

Total Raised

$6.5M

Rounds

12

Series B$1.2MAugust 2019